Publication | Closed Access

Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease

Alzheimer's DiseaseMedicineDementiaVascular Cognitive DisorderVascular DementiaNeuropharmacologySingle DoseRecognition MemoryNeurochemical BiomarkersNeuroscienceNeurologyAcetylcholinesterase Inhibitor VelnacrineCerebral Blood FlowPharmacologyLewy Body Dementia